Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin Lu-177-PP-F11N

Nathalie M. Grob, Roger Schibli, Martin Behe (Corresponding author), Thomas L. Mindt (Corresponding author)

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Article number2629
Number of pages12
JournalCancers
Volume13
Issue number11
DOIs
Publication statusPublished - Jun 2021

Austrian Fields of Science 2012

  • 301904 Cancer research
  • 301303 Medical biochemistry
  • 302055 Oncology

Keywords

  • cholecystokinin-2 receptor
  • peptidomimetics
  • minigastrin
  • molecular imaging
  • peptide receptor radionuclide therapy
  • MEDULLARY-THYROID CARCINOMA
  • PEPTIDES
  • PHARMACOKINETICS
  • 1,2,3-TRIAZOLES
  • RECEPTORS
  • TOXICITY
  • THERAPY
  • Molecular imaging
  • Peptidomimetics
  • Minigastrin
  • Cholecystokinin-2 receptor
  • Peptide receptor radionuclide therapy

Fingerprint

Dive into the research topics of 'Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin Lu-177-PP-F11N'. Together they form a unique fingerprint.

Cite this